Concepedia

S. Ebbinghaus

SE

5

Publications

261

Citations

5

H-Index

1999

Active since

Affiliations

University of Colorado Cancer Center(Current)

S. Ebbinghaus is an author at University of Colorado Cancer Center specializing in molecular pharmacology, oncology, and cancer therapeutics.

Top concepts

Publications per year

1999–2018

5

Publications

5

Characterization of a Novel Prostate-Specific Antigen–Activated Peptide-Doxorubicin Conjugate in Patients With Prostate Cancer

Robert S. DiPaola, John J. Rinehart, John Nemunaitis et al. · Journal of Clinical Oncology · 2002 · 83 citations

Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma

Diwakar Davar, Hong Wang, Joe-Marc Chauvin et al. · Journal of Clinical Oncology · 2018 · 79 citations · Full text

Treatment of patients with metastatic melanoma with bryostatin-1 - phase II study

R. Gonzalez, S. Ebbinghaus, T. K. Henthorn et al. · Melanoma Research · 1999 · 45 citations

Apo2L/TRAIL pharmacokinetics in a phase 1a trial in advanced cancer and lymphoma

Jia Ling, Roy S. Herbst, David S. Mendelson et al. · Journal of Clinical Oncology · 2006 · 33 citations

, , +19

Phase II study of synthadotin (SYN-D; ILX651) administered daily for 5 consecutive days once every 3 weeks (qdx5q3w) in patients (Pts) with inoperable locally advanced or metastatic melanoma

S. Ebbinghaus, E. Hersh, Casey Cunningham et al. · Journal of Clinical Oncology · 2004 · 21 citations

, , +19

Rows per page

1–5 of 5